CD4 and tuberculosis: Current evidence shows that the ELISA and the lateral flow formats of the assay do not have useful diagnostic accuracy among patients with CD4 counts greater than approximately 200 cells/μL or among those who have early clinical stages of disease (WHO stages 1 or 2) prior to TB diagnosis.